Skip to main content

Gemma Mayayo Marsal

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Gemma Mayayo Marsal

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Maria Cristina Caparros Felipe

Maria Cristina Caparros Felipe

Research technician
Transfusional Medicine
Read more
Maria Cecilia Juárez Dobjanschi

Maria Cecilia Juárez Dobjanschi

Predoctoral researcher
Systemic Diseases
Read more
Marina Tarrés Mercader

Marina Tarrés Mercader

Research technician
Gene Therapy at Nervous System
Read more
Alvaro Calabuig Goena

Alvaro Calabuig Goena

Junior researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.